There was one negative, the increased revenue did not translate into increased profits.
Slide 14 paints a very interesting picture.
Revenue + 25% - Good
Gross profit +24% - Good
NPATA + 10% - Not Good
There was a lot of leakage in S & M expenses, R & D (Ok with that - it is needed in their business) G & A and finance (understandable due to VIFOR acquisition).
I suspect that there will be some cost reduction occurring very soon in S & M to get Gross profit translating to NAPTA better.
HT1
Ann: CSL Half Year Results Announcement & Investor Presentation, page-4
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$301.20 |
Change
1.890(0.63%) |
Mkt cap ! $145.8B | |||
| Open | High | Low | Value | Volume |
| $300.94 | $301.98 | $299.44 | $160.0M | 531.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 586 | $301.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $301.32 | 1601 | 1 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| CSL (ASX) Chart |